HUP0104937A2 - Új, G-fehérjéhez kapcsolt receptorfehérje, DNS-e és ligandja - Google Patents
Új, G-fehérjéhez kapcsolt receptorfehérje, DNS-e és ligandjaInfo
- Publication number
- HUP0104937A2 HUP0104937A2 HU0104937A HUP0104937A HUP0104937A2 HU P0104937 A2 HUP0104937 A2 HU P0104937A2 HU 0104937 A HU0104937 A HU 0104937A HU P0104937 A HUP0104937 A HU P0104937A HU P0104937 A2 HUP0104937 A2 HU P0104937A2
- Authority
- HU
- Hungary
- Prior art keywords
- receptor
- receptor protein
- protein
- ligands
- proteins
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 7
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 title abstract 2
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 title abstract 2
- 102000005962 receptors Human genes 0.000 abstract 10
- 108020003175 receptors Proteins 0.000 abstract 10
- 150000001875 compounds Chemical class 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 238000012216 screening Methods 0.000 abstract 3
- 108091006027 G proteins Proteins 0.000 abstract 2
- 102000030782 GTP binding Human genes 0.000 abstract 2
- 108091000058 GTP-Binding Proteins 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 206010012335 Dependence Diseases 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000001638 cerebellum Anatomy 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30594998 | 1998-10-27 | ||
| JP2771099 | 1999-02-04 | ||
| JP5720799 | 1999-03-04 | ||
| JP27622599A JP4486187B2 (ja) | 1998-10-27 | 1999-09-29 | 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド |
| PCT/JP1999/005905 WO2000024890A1 (en) | 1998-10-27 | 1999-10-26 | Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0104937A2 true HUP0104937A2 (hu) | 2002-04-29 |
Family
ID=27458743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104937A HUP0104937A2 (hu) | 1998-10-27 | 1999-10-26 | Új, G-fehérjéhez kapcsolt receptorfehérje, DNS-e és ligandja |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6699965B1 (enExample) |
| EP (1) | EP1126028B1 (enExample) |
| JP (1) | JP4486187B2 (enExample) |
| KR (1) | KR20010085974A (enExample) |
| CN (1) | CN1324405A (enExample) |
| AT (1) | ATE394485T1 (enExample) |
| AU (1) | AU6230699A (enExample) |
| BR (1) | BR9914835A (enExample) |
| CA (1) | CA2347294A1 (enExample) |
| CZ (1) | CZ20011358A3 (enExample) |
| DE (1) | DE69938666D1 (enExample) |
| HU (1) | HUP0104937A2 (enExample) |
| ID (1) | ID28288A (enExample) |
| IL (1) | IL142428A0 (enExample) |
| NO (1) | NO20012059L (enExample) |
| NZ (1) | NZ510977A (enExample) |
| PL (1) | PL347553A1 (enExample) |
| SK (1) | SK5502001A3 (enExample) |
| WO (1) | WO2000024890A1 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002536989A (ja) * | 1999-02-24 | 2002-11-05 | メルク エンド カムパニー インコーポレーテッド | ガラニン受容体と類似したｇタンパク質共役受容体 |
| EP1273658A4 (en) * | 2000-03-30 | 2004-08-11 | Takeda Chemical Industries Ltd | NEW PROTEIN, THEIR DNA AND METHOD FOR THE PRODUCTION THEREOF |
| EP1168259A3 (en) | 2000-06-28 | 2003-12-17 | Hitachi, Ltd. | Data management method and system for IC card |
| AU8020201A (en) * | 2000-08-30 | 2002-03-13 | Wakenyaku Co Ltd | Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same |
| JP2002109169A (ja) | 2000-09-29 | 2002-04-12 | Hitachi Ltd | 作業支援方法並びにシステム及び作業支援方法を記録した記録媒体 |
| ATE416784T1 (de) | 2000-12-01 | 2008-12-15 | Takeda Pharmaceutical | Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz |
| WO2002059344A2 (en) * | 2000-12-18 | 2002-08-01 | Merck & Co., Inc. | Gpr54 g protein-coupled receptor |
| WO2002057309A1 (fr) * | 2001-01-18 | 2002-07-25 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice couplee a la proteine g et adn de cette proteine |
| WO2002072816A1 (fr) * | 2001-02-26 | 2002-09-19 | Takeda Chemical Industries, Ltd. | Proteine de recepteur murin de type kiss-1 et adn correspondant |
| WO2002083735A1 (fr) * | 2001-04-06 | 2002-10-24 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice et son adn |
| AU2008201995A1 (en) * | 2001-09-18 | 2008-05-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treament of tumor |
| KR101008758B1 (ko) | 2001-09-18 | 2011-01-14 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물 |
| CA2460803A1 (en) | 2001-09-19 | 2003-04-03 | Takeda Chemical Industries, Ltd. | Antibody against metastin and use thereof in diagnosing pregnancy |
| AU2003201854A1 (en) * | 2002-01-11 | 2003-07-30 | Takeda Chemical Industries, Ltd. | PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
| JP2006521082A (ja) * | 2002-09-11 | 2006-09-21 | ジェネンテック・インコーポレーテッド | 免疫関連疾患の治療のための新規組成物と方法 |
| US20060241051A1 (en) | 2002-12-26 | 2006-10-26 | Chieko Kitada | Metastin derivatives and use thereof |
| US6800611B2 (en) * | 2003-01-06 | 2004-10-05 | Takeda Chemical Industries, Ltd. | Metastin derivatives and their use |
| CA2518541C (en) * | 2003-03-12 | 2013-05-21 | Takeda Pharmaceutical Company Limited | Gonadal function improving agents |
| JP4639052B2 (ja) * | 2003-03-12 | 2011-02-23 | 武田薬品工業株式会社 | 性腺機能改善剤 |
| EP1464652A1 (en) * | 2003-04-02 | 2004-10-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases |
| AU2004234399A1 (en) * | 2003-04-28 | 2004-11-11 | Wyeth | Methods utilising G-protein coupled receptor 54 |
| WO2004101747A2 (en) * | 2003-05-07 | 2004-11-25 | The General Hospital Corporation | Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| WO2005040833A1 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Regulation of human metastin recognising receptors |
| JP4346650B2 (ja) | 2004-06-25 | 2009-10-21 | 武田薬品工業株式会社 | メタスチン誘導体およびその用途 |
| AR058584A1 (es) | 2005-12-22 | 2008-02-13 | Takeda Pharmaceutical | Derivados de metastina y uso de los mismos |
| US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| US20090099334A1 (en) * | 2005-12-22 | 2009-04-16 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| ITMI20061607A1 (it) | 2006-08-09 | 2008-02-10 | Maria Vincenza Carriero | Peptidi con attivita farmacologica |
| JO3048B1 (ar) | 2006-10-25 | 2016-09-05 | Takeda Pharmaceuticals Co | مشتقات متاستين واستخدامها |
| JPWO2009131191A1 (ja) * | 2008-04-24 | 2011-08-25 | 武田薬品工業株式会社 | メタスチン誘導体およびその用途 |
| WO2010013762A1 (ja) | 2008-07-30 | 2010-02-04 | 武田薬品工業株式会社 | メタスチン誘導体およびその用途 |
| MX2011003117A (es) * | 2008-09-19 | 2011-04-21 | Nektar Therapeutics | Conjugados polimericos de peptidos terapeuticos. |
| EP2340047A1 (en) * | 2008-09-19 | 2011-07-06 | Nektar Therapeutics | Polymer conjugates of kiss1 peptides |
| WO2010137022A1 (en) | 2009-05-27 | 2010-12-02 | Yeda Research And Development Co. Ltd | Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities |
| EP2873422A4 (en) | 2012-07-10 | 2015-12-30 | Takeda Pharmaceutical | PHARMACEUTICAL PREPARATION FOR INJECTION |
| CN109206481B (zh) | 2017-07-05 | 2023-08-18 | 尚华医药科技(江西)有限公司 | 一种肽类化合物、其应用及含其的组合物 |
| CN109212217B (zh) * | 2018-11-07 | 2021-09-10 | 李玉民 | 基于amy1a蛋白胃癌检测试剂盒及其使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436155A (en) * | 1991-12-31 | 1995-07-25 | Arch Development Corporation | Isolated DNA encoding a somatostatin receptor |
| EP0804575A1 (en) | 1994-08-11 | 1997-11-05 | Takeda Chemical Industries, Ltd. | G protein coupled receptor protein, production, and use thereof |
| WO1997013778A1 (en) | 1995-10-11 | 1997-04-17 | The Penn State Research Foundation | A metastasis suppressor gene |
| US6010877A (en) * | 1997-01-10 | 2000-01-04 | Smithkline Beecham Corporation | cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| US5851798A (en) * | 1997-01-27 | 1998-12-22 | Smithkline Beecham Corporation | Nucleic acid encoding human GPR14 receptor |
| US6420526B1 (en) * | 1997-03-07 | 2002-07-16 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| CA2283299A1 (en) | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| JP2002536989A (ja) * | 1999-02-24 | 2002-11-05 | メルク エンド カムパニー インコーポレーテッド | ガラニン受容体と類似したｇタンパク質共役受容体 |
| US20020077469A1 (en) * | 1999-03-10 | 2002-06-20 | Borowsky Beth E. | DNA encoding orphan SNORF11 receptor |
| CA2518541C (en) * | 2003-03-12 | 2013-05-21 | Takeda Pharmaceutical Company Limited | Gonadal function improving agents |
-
1999
- 1999-09-29 JP JP27622599A patent/JP4486187B2/ja not_active Expired - Fee Related
- 1999-10-26 EP EP99949421A patent/EP1126028B1/en not_active Expired - Lifetime
- 1999-10-26 US US09/830,428 patent/US6699965B1/en not_active Expired - Fee Related
- 1999-10-26 NZ NZ510977A patent/NZ510977A/xx unknown
- 1999-10-26 IL IL14242899A patent/IL142428A0/xx unknown
- 1999-10-26 CZ CZ20011358A patent/CZ20011358A3/cs unknown
- 1999-10-26 DE DE69938666T patent/DE69938666D1/de not_active Expired - Lifetime
- 1999-10-26 BR BR9914835-8A patent/BR9914835A/pt not_active IP Right Cessation
- 1999-10-26 PL PL99347553A patent/PL347553A1/xx not_active Application Discontinuation
- 1999-10-26 CN CN99812722A patent/CN1324405A/zh active Pending
- 1999-10-26 WO PCT/JP1999/005905 patent/WO2000024890A1/ja not_active Ceased
- 1999-10-26 CA CA002347294A patent/CA2347294A1/en not_active Abandoned
- 1999-10-26 SK SK550-2001A patent/SK5502001A3/sk unknown
- 1999-10-26 AU AU62306/99A patent/AU6230699A/en not_active Abandoned
- 1999-10-26 HU HU0104937A patent/HUP0104937A2/hu unknown
- 1999-10-26 KR KR1020017005344A patent/KR20010085974A/ko not_active Withdrawn
- 1999-10-26 AT AT99949421T patent/ATE394485T1/de not_active IP Right Cessation
- 1999-10-27 ID IDW20010936A patent/ID28288A/id unknown
-
2001
- 2001-04-26 NO NO20012059A patent/NO20012059L/no not_active Application Discontinuation
-
2004
- 2004-02-05 US US10/771,417 patent/US7314754B2/en not_active Expired - Fee Related
-
2007
- 2007-10-24 US US11/976,414 patent/US7608409B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4486187B2 (ja) | 2010-06-23 |
| ATE394485T1 (de) | 2008-05-15 |
| BR9914835A (pt) | 2002-06-18 |
| CN1324405A (zh) | 2001-11-28 |
| PL347553A1 (en) | 2002-04-08 |
| US20080131976A1 (en) | 2008-06-05 |
| EP1126028B1 (en) | 2008-05-07 |
| US20040180407A1 (en) | 2004-09-16 |
| IL142428A0 (en) | 2002-03-10 |
| EP1126028A4 (en) | 2002-11-27 |
| US6699965B1 (en) | 2004-03-02 |
| ID28288A (id) | 2001-05-10 |
| AU6230699A (en) | 2000-05-15 |
| US7608409B2 (en) | 2009-10-27 |
| WO2000024890A1 (en) | 2000-05-04 |
| NO20012059D0 (no) | 2001-04-26 |
| DE69938666D1 (de) | 2008-06-19 |
| CA2347294A1 (en) | 2000-05-04 |
| JP2000312590A (ja) | 2000-11-14 |
| US7314754B2 (en) | 2008-01-01 |
| NO20012059L (no) | 2001-06-26 |
| NZ510977A (en) | 2002-10-25 |
| KR20010085974A (ko) | 2001-09-07 |
| SK5502001A3 (en) | 2002-01-07 |
| EP1126028A1 (en) | 2001-08-22 |
| CZ20011358A3 (cs) | 2001-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104937A2 (hu) | Új, G-fehérjéhez kapcsolt receptorfehérje, DNS-e és ligandja | |
| Yang et al. | Human group-specific component (Gc) is a member of the albumin family. | |
| HIMMLER et al. | Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein | |
| US7999069B2 (en) | EphB receptor-binding peptides | |
| US6555111B2 (en) | Method of inhibiting the cytocidal effect of TNF with TNF receptor-specific antibodies | |
| ATE253111T1 (de) | Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung | |
| JP3164865B2 (ja) | 無細胞レセプター結合アッセイ、その作製および使用 | |
| DE60123998T2 (de) | Lösliche zcyctor 11 cytokinrezeptoren | |
| JPH09504030A (ja) | Ｃｎｔｆ族アンタゴニスト | |
| JP2005502584A5 (enExample) | ||
| Coulthard et al. | Characterization of the Epha1 receptor tyrosine kinase: expression in epithelial tissues | |
| JPH07506486A (ja) | 免疫グロブリンＥの高アフィニティレセプタのヒトβサブユニットの分離，特性化および用法 | |
| DE69031914T2 (de) | Rezeptor für granulozyten-macrophagen-koloniestimulierungsfaktor und seine derivate | |
| JP4208960B2 (ja) | オピオイドレセプター遺伝子 | |
| DE965041T1 (de) | Methode zum identifizieren von modulatoren der zelloberflächenmembranrezeptoren,nützlich zur behandlung von krankheiten | |
| EP1257822A4 (en) | HER-2 BINDING ANTAGONISTS | |
| US5629283A (en) | Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof | |
| ATE364627T1 (de) | G-protein gekoppelter rezeptor mit vergrösserter, extrazellulärer domäne | |
| Cullen et al. | Sequence requirements for ligand binding and cell surface expression of the Tac antigen, a human interleukin-2 receptor. | |
| PT648783E (pt) | Inibidores do fnt | |
| Anderson et al. | Beta adrenoreceptors in the rabbit bladder detrusor muscle. | |
| US6750322B2 (en) | Guanosine triphosphate (GTP) binding protein-coupled receptor proteins | |
| DE60109412T2 (de) | Therapeutische peptide | |
| DE69735424T2 (de) | Verfahren und mittel zur modifikation der komplementaktivierungskaskade | |
| US20040241757A1 (en) | Novel screening method using prokineticin receptor |